In the last trading session, 9.15 million Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) shares changed hands as the company’s beta touched 0.87. With the company’s per share price at $14.06 changed hands at $0.08 or 0.57% during last session, the market valuation stood at $15.76B. TEVA’s last price was a discount, traded about -2.92% off its 52-week high of $14.47. The share price had its 52-week low at $7.09, which suggests the last value was 49.57% up since then. When we look at Teva- Pharmaceutical Industries Ltd. ADR’s average trading volume, we note the 3-month average coming to 9.24 million.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) trade information
Instantly TEVA was in green as seen at the end of in last trading. With action -0.28%, the performance over the past five days has been red. The jump to weekly highs of 14.19 added 0.57% to the stock’s daily price. The company’s shares are showing year-to-date upside of 34.67%, with the 5-day performance at -0.28% in the red. However, in the 30-day time frame, Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) is -1.33% down.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) estimates and forecasts
Data shows that the Teva- Pharmaceutical Industries Ltd. ADR share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 60.14% over the past 6 months, a -7.42% in annual growth rate that is considerably lower than the industry average of 21.90%. Year-over-year growth is forecast to reach 0.10% up from the last financial year.
Consensus estimates given by 7 financial analysts project the company’s revenue in the current quarter to hit an average of 3.73B. 7 analysts are of the opinion that Teva- Pharmaceutical Industries Ltd. ADR’s revenue for the current quarter will be 4B. The company’s revenue for the corresponding quarters a year ago was 3.63B. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 2.80%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 26.63%. The 2024 estimates are for Teva- Pharmaceutical Industries Ltd. ADR earnings to decrease by -6.13%, but the outlook for the next 5-year period is at 1.60% per year.
